Wed, December 19, 2018
Tue, December 18, 2018
Mon, December 17, 2018
Fri, December 14, 2018
Thu, December 13, 2018
Wed, December 12, 2018
Tue, December 11, 2018
Mon, December 10, 2018
Fri, December 7, 2018
Thu, December 6, 2018
Wed, December 5, 2018
Tue, December 4, 2018
Mon, December 3, 2018
Fri, November 30, 2018
Thu, November 29, 2018
Wed, November 28, 2018
Tue, November 27, 2018
Mon, November 26, 2018
Fri, November 23, 2018
Wed, November 21, 2018
Tue, November 20, 2018
Mon, November 19, 2018
Fri, November 16, 2018

David Lewis Maintained (ABT) at Buy with Increased Target to $82 on, Dec 4th, 2018


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. with-increased-target-to-82-on-dec-4th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI


David Lewis of Morgan Stanley, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $80 to $82 on, Dec 4th, 2018.

David has made no other calls on ABT in the last 4 months.



There are 5 other peers that have a rating on ABT. Out of the 5 peers that are also analyzing ABT, 0 agree with David's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with David


  • Isaac Ro of "Goldman Sachs" Upgraded from Hold to Strong Buy and Increased Target to $81 on, Friday, November 30th, 2018
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $79 on, Thursday, October 18th, 2018
  • Matthew Taylor of "Barclays" Initiated at Buy and Held Target at $80 on, Tuesday, October 16th, 2018
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $81 on, Monday, October 8th, 2018
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $80 on, Monday, September 24th, 2018

Publication Contributing Sources